Skip to main content
OpenTrials
Completed

NCT Number: NCT04347759

Symptom Care at Home-Heart Failure

This project aims to adapt a computer-interface telephonic interactive voice response system that monitors symptoms and provides real-time, self-management coaching messages based on heart failure patient-reported outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Emory Clinic, Atlanta, Georgia, United States

Loading trial locations.

About this study

Keeping heart failure (HF) patients at home with a low symptom burden after hospital discharge is challenging. HF patients may suffer worsening symptoms over time without seeking medical advice leading to poor quality of life and readmission to the hospital. Evidence shows that delay in HF symptom recognition and poor self-management are associated with unplanned HF-related emergency department (ED) visits and rehospitalizations. Clinical trials aimed at preventing rehospitalization using telemonitoring of physical changes, such as daily weights, have shown limited utility.

Understanding patients' experiences of HF symptoms and engagement in appropriate self-management are key to maintaining disease stability. Cancer studies have shown that symptom burden can be effectively decreased using automated home monitoring and self-management coaching. A recent cancer study has demonstrated that patients receiving cancer chemotherapy achieved a 40% reduction in symptoms using Symptom Care at Home (SCH), a telephone-computer interface interactive voice response (IVR) system pairing patient-reported symptoms with automated real-time self-management coaching. While a few HF studies have used interventions that monitored symptoms, no studies have tested a system that monitors and provides real-time self-management coaching tailored to specific patient-reported outcomes (PRO). The objective of this study is to adapt the SCH system to HF and conduct a pilot randomized controlled trial (RCT) to assess the feasibility, acceptability, and preliminary efficacy of the Symptom Care at Home - Heart Failure (SCH-HF) system.

Participants are randomized to receive usual care consisting of automated daily monitoring, or to receive the intervention, which includes automated daily monitoring and real-time self-management coaching.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Medical diagnosis of heart failure
  • New York Heart Association (NYHA) Classification of the Stages of Heart Failure Class I - IV
  • Ability to read, understand, and speak in English
  • Will be discharged home
  • Has daily access to any type of telephone

Exclusion criteria

  • A score of 0 or 1-2 with an abnormally drawn clock on the Mini-Cog
  • Discharged home on hospice care
  • End-stage renal failure
  • Wait list for heart transplant

Treatment and study plan

Coaching Messages

Behavioral

Participants receive real-time self-management coaching messages based on the severity of their symptoms. When participants call, the IVR system will ask them about each of the selected symptoms, and the patient will report symptom presence and severity numerically with the touch-tone keypad.

Automated Daily Monitoring

Behavioral

Participants report daily symptoms and symptom severity. There are three categories of severity based on a numeric scale of 1 to 3 for mild symptoms, 4 to 7 for moderate symptoms, and 8 to 10 for severe symptoms.

Primary outcomes

  1. Self-Care of Heart Failure Index (SCHFI) Score

    Time frame: Baseline (at the time of hospital discharge, pre-intervention), Day 30 (post-intervention)

    The Self-Care of Heart Failure Index, version 7.2, is a 29-item instrument with separate scales assessing self-care maintenance, symptom perception, and self-care management. Responses to items are given on a 5-point scale. Scores for each of the three scales are summed and standardized with scores ranging from 0 to 100. Higher scores indicate better self-care, with scores of 70 or higher indicating adequate levels of heart failure self-care.

Secondary outcomes

  1. Number of eligible patients recruited

    Time frame: Baseline (at the time of hospital discharge, pre-intervention)

    Feasibility is determined by the number of eligible patients who enroll in the study.

  2. Number of participants using the intervention

    Time frame: Up to Day 30 (post-intervention)

    Feasibility is determined by the number of participants who complete the daily monitoring reports.

  3. Days on Study

    Time frame: Up to Day 30 (post-intervention)

    Feasibility is determined by the number of days that participants remain in the study.

  4. Satisfaction with Phone Calls

    Time frame: Day 30 (post-intervention)

    Acceptability is assessed using a 10-point Likert scale asking participants how satisfied they were with the phone calls. Responses are given such that 10 means the participant was very satisfied and 1 means they were not satisfied at all.

Other outcomes

  1. Number of Participants Re-hospitalized

    Time frame: Up to 30 days after hospital discharge

    The re-hospitalization rate will be an exploratory endpoint between study arms.

Sponsors and collaborators

Lead sponsor

Emory University

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)
  • University of Utah

Registry information

Official study title

Symptom Care at Home-Heart Failure: Developing and Piloting a Symptom Monitoring and Self-Management Coaching System for Patients With Heart Failure

Acronym: SCH-HF

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Apr 15, 2020
Registry last updated
Jun 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.